XPH Holdings Information

XPH is an equity ETF with a total of 67 individual holdings. The top holdings are Amylyx Pharmaceuticals stock at 3.98%, Crinetics Pharmaceuticals at 3.43%, MBX Biosciences at 3.07%, Definium Therapeutics at 2.74%, and AtaiBeckley at 2.71%.

Total Holdings

Top 10 Percentage

27.00%

Asset Class

Equity

ETF Category

Health

Assets

584.37M

PE Ratio

14.96

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMLX	Amylyx Pharmaceuticals, Inc.	3.98%	592,761
2	CRNX	Crinetics Pharmaceuticals, Inc.	3.43%	232,474
3	MBX	MBX Biosciences, Inc.	3.07%	257,455
4	DFTX	Definium Therapeutics, Inc.	2.74%	343,312
5	ATAI	AtaiBeckley Inc.	2.71%	2,110,723
6	OMER	Omeros Corporation	2.50%	782,209
7	ELVN	Enliven Therapeutics, Inc.	2.23%	215,635
8	NUVB	Nuvation Bio Inc.	2.20%	1,742,037
9	CORT	Corcept Therapeutics Incorporated	2.12%	102,135
10	ETON	Eton Pharmaceuticals, Inc.	2.02%	188,463
11	EWTX	Edgewise Therapeutics, Inc.	1.96%	242,359
12	TRVI	Trevi Therapeutics, Inc.	1.95%	595,414
13	OCUL	Ocular Therapeutix, Inc.	1.86%	912,878
14	NKTR	Nektar Therapeutics	1.86%	140,513
15	MRK	Merck & Co., Inc.	1.78%	67,002
16	PRGO	Perrigo Company plc	1.74%	714,284
17	BMY	Bristol-Myers Squibb Company	1.69%	143,502
18	MAZE	Maze Therapeutics, Inc.	1.68%	324,408
19	TARS	Tarsus Pharmaceuticals, Inc.	1.67%	130,220
20	MANE	Veradermics, Incorporated	1.66%	85,807
21	ALMS	Alumis Inc.	1.66%	397,730
22	AMRX	Amneal Pharmaceuticals, Inc.	1.64%	520,791
23	LGND	Ligand Pharmaceuticals Incorporated	1.63%	32,148
24	HROW	Harrow, Inc.	1.61%	222,243
25	LQDA	Liquidia Corporation	1.60%	122,281

Showing 25 of 67 holdings

Subscribe to see the full list

Activate Now

As of Aug 19, 2026